m+Medelevator.RU
← Поиск публикаций
Journal of autoimmunity · 2026

PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Orefice Nicola Salvatore, Meijns Niels R C, Di Martino Emanuele, Schepers Melissa, Tiane Assia, Schenk Geert J, Kearney Hugh, Vanmierlo Tim, Luchicchi Antonio

Аннотация

Proteins affect most physiological functions in cells and play a key role in maintaining cellular homeostasis. Protein function is tuned at multiple levels, including synthesis and degradation, intracellular localization, and posttranslational modifications (PTMs). PTMs are a key chemical modification for regulating protein biological activity, including protein-folding relevant shifts in electrical charge, protein-protein interactions, and hydrogen bond formation. Such chemical changes can also result in protein unfolding or denaturation. PTMs can target proteins across multiple cellular compartments, including the cell membrane, cytoplasm, nucleus, endoplasmic reticulum, and mitochondria, playing crucial roles in regulating cellular processes, and their dysregulation is linked to the development of numerous diseases. It is well-established that various autoimmune conditions, including multiple sclerosis (MS), are influenced by the PTMs of endogenous proteins. This review adopts an integrated perspective on PTMs, with a particular focus on the citrullination of myelin basic protein (MBP). It moves beyond the traditional view of MS solely as an autoimmune disease, highlighting the broader implications of this initial chemical event, including the role of PAD2, in early disease onset and progression.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты